A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

Cited by (1,002)

Items 801–900 of 1,002

  1. The prevalence and the effect of interferon -γ in the comorbidity of rheumatoid arthritis and depression
    Huan Ren, Fengmei Lin, Lifang Wu, Lina Tan, Lili Lu, Xiuli Xie, Yang Zhang, Yanni Bao, Yuchen Ma, Xiaoqin Huang et al. · 2022 · Behavioural Brain Research
  2. Zuojinwan ameliorates CUMS-induced depressive-like behavior through inducing ubiquitination of MyD88 via SPOP/MyD88/NF-κB pathway
    Weiwei Tao, Kunhan Su, Yuzhen Huang, Zihan Lu, Yan Wang, Lu Yang, Guoying Zhang, Wanli Liu · 2023 · Journal of Ethnopharmacology
  3. Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia
    Shujuan Pan, Yunlong Tan, Shangwu Yao, Xiaoyan Zhao, Jing Xiong · 2016 · Psychiatry Research
  4. The NF-κB signaling pathway: an important therapeutic target in psychiatric disorders
    Meric Adil Altinoz, Bahri İnce, C Tek, Vinod H. Srihari, Sinan Gülöksüz · 2016 · Molecular Psychiatry
  5. NT-proBNP is a potential mediator between reduced ejection fraction and depression in patients with heart failure
    Pedro Zuzarte, Gustavo Scola, Angela Duong, Kari Kostiw, Maria Luísa Figueira, Atilio Costa Vitali · 2018 · Journal of Psychiatric Research
  6. Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study)
    Dominik Strzelecki, Małgorzata Urban‐Kowalczyk, Adam Wysokiński · 2018 · Psychiatry Research
  7. Reduction in serum IL-1β, IL-6, and IL-18 levels and Beck Depression Inventory-II score by combined sertraline and ketoprofen administration in major depressive disorder: A clinical trial
    Hussein Kadhem Al‐Hakeim, Ahmed Jasim Twayej, Arafat Hussein Al-Dujaili · 2018 · Neurology Psychiatry and Brain Research
  8. Body Mass Index Predicts Decline in Executive Function in Bipolar Disorder: Preliminary Data of a 12-Month Follow-up Study
    Nina Dalkner, Susanne Bengesser, Armin Birner, Alexandra Rieger, Julia Seebauer, Martina Platzer, Carlo Hamm, Alexander Maget, Robert Queissner, René Pilz et al. · 2020 · Neuropsychobiology
  9. Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways
    Karina S. MacDowell, Eva Munarriz‐Cuezva, J. Javier Meana, Juan Carlos Leza, Jorge Emilio Ortega · 2021 · Frontiers in Pharmacology
  10. The Role of Aberrations in the Immune-inflammatory Reflex System (IRS) and the Compensatory Immune-regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: The IRS-CIRS Theory of Schizophrenia
    Chutima Roomruangwong, Cristiano de Souza Noto, Buranee Kanchanatawan, George Anderson, Marta Kubera, Andre Ferrer Carvalho, Michael H. J. Maes · 2018 · Preprints.org
  11. Aerobic Exercise Improves the Overall Outcome of Type 2 Diabetes Mellitus Among People With Mental Disorders
    Jiaxuan He, Fan Liu, Peiye Xu, Ting Xu, Haiyang Yu, Baihui Wu, Hanbing Wang, Jia Chen, Kun Zhang, Junbei Zhang et al. · 2024 · Depression and Anxiety
  12. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in US Veterans with schizophrenia and bipolar disorder
    Teodor T. Postolache, Deborah R. Medoff, Clayton H. Brown, Li Fang, Sanjaya K. Upadhyaya, Christopher A. Lowry, Michael J. Miller, Julie A. Kreyenbuhl · 2021 · Pteridines
  13. Childhood trauma, IL-6 and weaker suppression of the default mode network (DMN) during theory of mind (ToM) performance in schizophrenia
    Sinéad King, David Mothersill, Laurena Holleran, Saahithh Redddi Patlola, Ross McManus, Marcus Kenyon, Colm McDonald, Brian P. Hallahan, Aiden Peter Corvin, Derek W. Morris et al. · 2022 · Brain Behavior & Immunity - Health
  14. Integrative analysis to identify shared mechanisms between schizophrenia and bipolar disorder and their comorbidities
    Vinay Srinivas Bharadhwaj, Sarah Mubeen, Astghik Sargsyan, Geena Mariya Jose, Stefan Geißler, Martin Hofmann‐Apitius, Daniel Domingo‐Fernándéz, Alpha Tom Kodamullil · 2022 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  15. Comparison of oxidative stress parameters, thiol-disulfide homeostasis, and pro-inflammatory cytokines levels in patients with bipolar disorder and their first-degree relatives
    Naci Polat, Hakan Beyaztaş, Selman Aktaş, Özgür Maden, Eray Metin Güler · 2023 · Journal of Psychiatric Research
  16. IL-1ra treatment prevents chronic social defeat stress-induced depression-like behaviors and glutamatergic dysfunction via the upregulation of CREB-BDNF
    Mingxing Li, Li Han, Junli Xiao, Song Zhang, Guangya Liu, Xuejiao Sun · 2023 · Journal of Affective Disorders
  17. Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia
    Yin Cao, Yayun Xu, Qingrong Xia, Feng Shan, Jun Liang · 2023 · Neuropsychiatric Disease and Treatment
  18. MicroRNAs and pro-inflammatory cytokines as candidate biomarkers for recent-onset psychosis
    Ali Reza Shafiee‐Kandjani, Negin Nezhadettehad, Sara Farhang, Richard Bruggeman, Dariush Shanebandi, Mohammadbagher Hassanzadeh, Hosein Azizi · 2023 · BMC Psychiatry
  19. Impulsivity across severe mental disorders: a cross-sectional study of immune markers and psychopharmacotherapy
    Gabriela Hjell, Jaroslav Rokicki, Attila Szabó, René Holst, Natalia Tesli, Christina Bell, Thomas Fischer-Vieler, Maren Caroline Frogner Werner, Synve Hoffart Lunding, Monica B E G Ormerod et al. · 2023 · BMC Psychiatry
  20. Immunological Biomarkers as Predictors of Treatment Response in Psychotic Disorders
    Elif Bayram Orbe, Michael E. Benros · 2023 · Journal of Personalized Medicine
  21. The role of infections and inflammation in schizophrenia: review of the evidence
    Gellan K. Ahmed, Haidi Karam‐Allah Ramadan, Khaled Elbeh, Nourelhoda A. Haridy · 2024 · Middle East Current Psychiatry
  22. Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder
    Reza Rafizadeh, Anmol Sooch, Alessia Risi, Nicoline Bihelek, Kyler Kanegawa, Alasdair M. Barr, Randall F. White, Christian G. Schütz, Chad Bousman · 2024 · Journal of Psychopharmacology
  23. Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo
    Emma Sampson, Natalie T. Mills, Hikaru Hori, Micah Cearns, Kathrin Schwarte, Christa Hohoff, Klaus Oliver Schubert, Célia Fourrier, Bernhard Theodor Baune · 2024 · Brain Behavior and Immunity
  24. Transdiagnostic features of inflammatory markers and executive function across psychiatric disorders
    Tzu‐Yun Wang, Yun‐Hsuan Chang, Sheng-Yu Lee, Hui Hua Chang, Tsung-Yu Tsai, Huai‐Hsuan Tseng, Shao‐Ming Wang, Po See Chen, Kao Chin Chen, I Hui Lee et al. · 2024 · Journal of Psychiatric Research
  25. Targeting the Immune System With Pharmacotherapy in Schizophrenia
    Jennifer K. Melbourne, Benjamin Feiner, Cherise Rosen, Rajiv P. Sharma · 2017 · Current Treatment Options in Psychiatry
  26. Increased risk of bipolar disorder in patients with scabies: A nationwide population-based matched-cohort study
    Chien‐Yu Lin, Fung-Wei Chang, Jing-Jung Yang, Chun-Hung Chang, Chia-Lun Yeh, Wei‐Te Lei, Chun-Fa Huang, Jui‐Ming Liu, Ren‐Jun Hsu · 2017 · Psychiatry Research
  27. Cytokines in agitated and non-agitated patients admitted to an acute psychiatric department: A cross-sectional study
    Jeanette Brun Larsen, Astrid Kamilla Stunes, Arne Vaaler, Solveig Klæbo Reitan · 2019 · PLoS ONE
  28. Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia
    Shang‐Ying Tsai, Martha Sajatovic, Jung‐Lung Hsu, Kuo‐Hsuan Chung, Pao‐Huan Chen, Yu‐Jui Huang · 2020 · International Journal of Geriatric Psychiatry
  29. The longitudinal relation between depressive symptoms and change in self-rated health: A nationwide cohort study
    Siyuan Liu, Yanan Qiao, Ying Wu, Yueping Shen, Chaofu Ke · 2021 · Journal of Psychiatric Research
  30. Detailed Postmortem Profiling of Inflammatory Mediators Expression Revealed Post-inflammatory Alternation in the Superior Temporal Gyrus of Schizophrenia
    Ryuta Izumi, Mizuki Hino, Akira Wada, Atsuko Nagaoka, Takashi Kawamura, Tsutomu Mori, Makoto Sainouchi, Akiyoshi Kakita, Kiyoto Kasai, Yasuto Kunii et al. · 2021 · Frontiers in Psychiatry
  31. Neurobiological substrates of major psychiatry disorders: transdiagnostic associations between white matter abnormalities, neuregulin 1 and clinical manifestation
    Jia Duan, Yange Wei, Fay Y. Womer, Xizhe Zhang, Miao Chang, Yue Zhu, Zhuang Liu, Chao Li, Zhiyang Yin, Ran Zhang et al. · 2021 · Journal of Psychiatry and Neuroscience
  32. COVID-19 and Psychotic Symptoms: the View from Psychiatric Immunology
    Sarvodaya Tripathy, Nitika Singh, Amit Kumar Singh, Sujita Kumar Kar · 2021 · Current Behavioral Neuroscience Reports
  33. Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer’s disease
    Xiaonan Wang, Di Wang, Fei Su, Chunmei Li, Min Chen · 2022 · Annals of Translational Medicine
  34. Interleukin-18 signaling system links to agitation in severe mental disorders
    Gabriela Hjell, Attila Szabó, Lynn Egeland Mørch-Johnsen, René Holst, Natalia Tesli, Christina Bell, Thomas Fischer-Vieler, Maren Caroline Frogner Werner, Synve Hoffart Lunding, Monica B E G Ormerod et al. · 2022 · Psychoneuroendocrinology
  35. Immunoinflammatory processes: Overlapping mechanisms between obesity and eating disorders?
    Édith Breton, Jocelyn Fotso Soh, Linda Booij · 2022 · Neuroscience & Biobehavioral Reviews
  36. Mapping the structure of depression biomarker research: A bibliometric analysis
    Xiangjie Guo, Peng Wu, Xiao Ping Jia, Yiming Dong, Chun‐Mei Zhao, Niannian Chen, Zhiyong Zhang, Yu-ting Miao, Keming Yun, Cairong Gao et al. · 2022 · Frontiers in Psychiatry
  37. Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia
    Florian W. Adraoui, Linda Douw, Gerard J.M. Martens, Dorien A. Maas · 2023 · International Journal of Molecular Sciences
  38. Inhibition of TNFα-induced interleukin-6 gene expression by barley (Hordeum vulgare) ethanol extract in BV-2 microglia
    Jihye Choi, Juhwan Kim, Dong Yeong Min, Euitaek Jung, Yoongho Lim, Soon Young Shin, Young Han Lee · 2019 · Genes & Genomics
  39. Harmonised collection of data in youth mental health: Towards large datasets
    Suzie Lavoie, Kelly Allott, G. Paul Amminger, Cali Bartholomeusz, Maximus Berger, Michael J Breakspear, Anjali K. Henders, Rico Lee, Ashleigh Peng Lin, Patrick D. McGorry et al. · 2019 · Australian & New Zealand Journal of Psychiatry
  40. Impact of data extraction errors in meta-analyses on the association between depression and peripheral inflammatory biomarkers: an umbrella review
    San Lee, Keum Hwa Lee, Kyung Mee Park, Sung Jong Park, Won Jae Kim, Jinhee Lee, Andreas Kronbichler, Lee Smith, Marco Solmi, Brendon Stubbs et al. · 2021 · Psychological Medicine
  41. NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity
    Chen Chen, Siqi Zhang, Ming Sheng, Wei Shao · 2025 · Mediators of Inflammation
  42. Rapid and simple analysis of disease-associated biomarkers of Taiwanese patients with schizophrenia using matrix-assisted laser desorption ionization mass spectrometry
    Tiao‐Lai Huang, Li‐Hua Lo, Jentaie Shiea, Hung Su · 2017 · Clinica Chimica Acta
  43. IL-6, homocysteine, and autism spectrum phenotypes: an investigation among adults with autism spectrum disorder and their first-degree relatives
    Barbara Carpita, Leonardo Massoni, Simone Battaglini, Lionella Palego, Ivan Mirko Cremone, Gabriele Massimetti, Laura Betti, Gino Giannaccini, Liliana Dell’Osso · 2023 · CNS Spectrums
  44. The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration
    Sunniva Fenn‐Moltu, J.F.W. Deakin, Richard Drake, Oliver David Howes, Stephen M. Lawrie, Shôn W. Lewis, Naghmeh Nikkheslat, James Walters, James Hunter MacCabe, Valeria Mondelli et al. · 2023 · Brain Behavior and Immunity
  45. Peripheral inflammation is linked with emotion and mental health in people with obesity. A “head to toe” observational study
    Charalampia Amerikanou, Evdokia Valsamidou, Stamatia-Angeliki Kleftaki, Aristea Gioxari, Konstantinos Koutoulogenis, Maria Aroutiounova, Ioannis Stergiou, Andriana C. Kaliora · 2023 · Frontiers in Endocrinology
  46. Neurofilaments – Small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span
    Julia Elmers, Lorenza S. Colzato, Katja Akgün, Tjalf Ziemssen, Christian Beste · 2023 · Ageing Research Reviews
  47. Cross-trait genome-wide association analysis of C-reactive protein level and psychiatric disorders
    Guy Hindley, Ole Kristian Drange, Aihua Lin, Gleda Kutrolli, Alexey A. Shadrin, Nadine Parker, Kevin Sean O’Connell, Linn Nilsen Rødevand, Weiqiu Cheng, Shahram Bahrami et al. · 2023 · Psychoneuroendocrinology
  48. Genetic and inflammatory effects on childhood trauma and cognitive functioning in patients with schizophrenia and healthy participants
    Emma Corley, Saahithh Redddi Patlola, Aodán Laighneach, Aiden Peter Corvin, Ross McManus, Marcus Kenyon, John P. Kelly, Declan Patrick McKernan, Sinéad King, Brian P. Hallahan et al. · 2023 · Brain Behavior and Immunity
  49. Causal role of immune cells in major depressive disorder and bipolar disorder: Mendelian randomization (MR) study
    Yi Zhang, San-Wang Wang, Jiahao Ding, Xin Wen, Tingting Li, Lu Yang, Jintao Peng, Yingying Dong, Weifeng Mi, Yujun Gao et al. · 2024 · Journal of Affective Disorders
  50. The Interrelationships between Cytokines and Schizophrenia: A Systematic Review
    Haibing Lv, Meng Guo, Guo Chuang, Kuanjun He · 2024 · International Journal of Molecular Sciences
  51. A cross-section study of the comparison of plasma inflammatory cytokines and short-chain fatty acid in patients with depression and schizophrenia
    Huan Yu, Rui Li, Xue‐jun Liang, Wenmao Yang, Lin Guo, Ling Liu, Qingrong Tan, Zhengwu Peng · 2024 · BMC Psychiatry
  52. Association of motoric cognitive risk syndrome with depression in older adults: a meta-analysis and systematic review of cross-sectional and cohort studies
    Shi Zhou, Niansi Ye, Xueting Liu, Yucan Li, Yating Ai, Xiaotong Wang, Pengjun Zhou, Hui Hu · 2024 · BMC Geriatrics
  53. DNA hydrolysing IgG catalytic antibodies: an emerging link between psychoses and autoimmunity
    Rajendran Ramesh, Aparna Sundaresh, Ravi Philip Rajkumar, Vir Singh Negi, Mookambeswaran Arunachalam Vijayalakshmi, Rajagopal Krishnamoorthy, Ryad Tamouza, Marion Leboyer, A. S. Kamalanathan · 2021 · Schizophrenia
  54. Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients
    Heather K. Hughes, Emily Mills-Ko, Houa T. Yang, Tyler A. Lesh, Cameron S. Carter, Paul Ashwood · 2021 · Frontiers in Cellular Neuroscience
  55. Identification of potential blood biomarkers for early diagnosis of schizophrenia through RNA sequencing analysis
    Zhijun Li, Xinwei Li, Mengdi Jin, Yang Liu, Yang He, Ningning Jia, Xingyao Cui, Yane Liu, Guoyan Hu, Qiong Yu · 2022 · Journal of Psychiatric Research
  56. Effect of quetiapine on inflammation and immunity: a systematic review
    Marco Ferrari, Marco Godio, Stefano Martini, Camilla Callegari, Marco Cosentino, Franca Marino · 2022 · International Journal of Psychiatry in Clinical Practice
  57. Attenuation of the levels of pro-inflammatory cytokines prevents depressive-like behavior during ethanol withdrawal in mice
    E.B. Fraga-Junior, Isadora Luiza Fernandes, Christopher Alecsander Herane Rohden, Diego Luiz Doneda, H.N. Ynoue, Fabrício Rios-Santos, E. Lima, Z.S. Buss, Samuel Vandresen-Filho · 2022 · Brain Research Bulletin
  58. Rutin co-treatment prevented cognitive impairment/depression-like behavior and decreased IDO activation following 35 days of ethanol administration in male Wistar rats
    Azubuike Peter Ebokaiwe, Doris Olachi Obasi, Uket Obeten, Tochukwu Onyemuche · 2022 · Alcohol
  59. Longitudinal study of inflammation and relapse in schizophrenia
    Brian J. Miller, Henrique de Paula Lemos, Nina R. Schooler, DONALD C. GOFF, Alex J. Kopelowicz, John Lauriello, Theo C. Manschreck, Alan J. Mendelowitz, Del D. Miller, Joanne B. Severe et al. · 2023 · Schizophrenia Research
  60. The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs
    Dmitrii D. Markov, Oleg V. Dolotov, Igor A. Grivennikov · 2023 · International Journal of Molecular Sciences
  61. Gene expression profiling of monocytes in recent-onset schizophrenia
    Raphael Kübler, Paul R. Ormel, Iris E. Sommer, René S. Kahn, Lot D. de Witte · 2023 · Brain Behavior and Immunity
  62. Meta-analysis of soluble tumour necrosis factor receptors in severe mental illnesses
    Xue Xin Goh, Pek Yee Tang, Shiau Foon Tee · 2023 · Journal of Psychiatric Research
  63. Cortical biometals: Changed levels in suicide and with mood disorders
    Brian Dean, Linh Q. Lam, Elizabeth Scarr, James A. Duce · 2018 · Journal of Affective Disorders
  64. Dopamine perturbation of gene co-expression networks reveals differential response in schizophrenia for translational machinery
    Mark Z. Kos, J. Duan, Alan R. Sanders, Lucy Blondell, Eugene I. Drigalenko, M. Carless, P. Gejman, H. Göring, Mgs. · 2018 · Translational Psychiatry
  65. Expression of Bcl-2 and Bax genes in peripheral blood lymphocytes of depressed and nondepressed individuals
    Meysam Amidfar, Zahra Karami, Gholam Reza Kheirabadi, Hamid Afshar, Abolghasem Esmaeili · 2019 · Journal of Research in Medical Sciences
  66. Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis
    Ta‐Chuan Yeh, Hsuan‐Te Chu, Chia‐Kuang Tsai, Hsin‐An Chang, Fu‐Chi Yang, San‐Yuan Huang, Chih‐Sung Liang · 2019 · Psychiatry Investigation
  67. Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages
    Jennifer K. Melbourne, Yanzhen Pang, Mi Rae Park, Niyati Sudhalkar, Cherise Rosen, Rajiv P. Sharma · 2019 · International Immunopharmacology
  68. Serum cytokines associated with behavior: A cross-sectional study in 5-year-old children
    Susana Barbosa, Olfa Khalfallah, Anne Forhan, Cédric Galéra, Barbara Heude, Nicolas Glaichenhaus, Laëtitia Davidovic · 2020 · Brain Behavior and Immunity
  69. A pro-inflammatory phenotype is associated with behavioural traits in children with Prader–Willi syndrome
    Maja Krefft, Dorota Frydecka, Gil Zalsman, Małgorzata Krzystek‐Korpacka, Robert Stanisław Śmigiel, Katarzyna Gębura, Katarzyna Bogunia‐Kubik, Błażej Misiak · 2020 · European Child & Adolescent Psychiatry
  70. Association of Peroxiredoxin 1 and brain-derived neurotrophic factor serum levels with depression and anxiety symptoms in patients with irritable bowel syndrome
    Yu Zhang, Yaxin Bi, Jie Chen, Shuang Li, Xiaxin Wu, Lu Zhang, Zhijie Lin, Sen Han, Shizhen Ding · 2020 · General Hospital Psychiatry
  71. Neuropsychiatric disorders: An immunological perspective
    Ernest Aw, Yingying Zhang, Esra Yalçın, U. Herrmann, Michael C. Carroll · 2021 · Advances in immunology
  72. Metabolic indexes of obesity in patients with common mental disorders in stable stage
    Xiaoling Li, Xiaojie Shi, Yukang Tan, Yang Wen Yu, Chaohua Tang, Guohong Xu, Xinglian Zhang, Hairong Liao, Xiancong Mai, Wensheng Chen et al. · 2022 · BMC Psychiatry
  73. Commentary: Causal associations between inflammation, cardiometabolic markers and schizophrenia: the known unknowns
    Golam Mohammed Khandaker · 2019 · International Journal of Epidemiology
  74. Evaluation of systemic immune inflammation index and neutrophil-to-lymphocyte ratio in schizophrenia, bipolar disorder and depression
    2024
  75. Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?
    Llorca-Bofí, Vicent, Bioque, Miquel, Font, Maria, Gich, Ignasi, Mur, Maria · 2023 · Journal of Psychiatric Research
  76. Autoantibodies and Inflammation in Schizophrenia
    Hiroki Shiwaku · 2025 · Psychiatry and Clinical Neurosciences
  77. Fructo‐oligofructose ameliorates 2,4‐dinitrofluorobenzene‐induced atopic dermatitis‐like skin lesions and psychiatric comorbidities in mice
    Shaoze Chen, Liu Tang, Tingting Nie, Mingyu Fang, Xiaoqin Cao · 2023 · Journal of the Science of Food and Agriculture
  78. Effect of fluvoxamine on plasma interleukin-6 in patients with major depressive disorder: a prospective follow-up study
    Xueqin Li, Danfeng Yan, Mei Liao, Li Zhang, Zexuan Li, Bangshan Liu, Yanjun Chen, Yan Zhang, Jin Liu, Lingjiang Li · 2023 · Frontiers in Psychiatry
  79. Identification of Immune-Linked Hub Genes and Diagnostic Model Construction in Schizophrenia
    Kun Lian, Zonglin Shen, Runxu Yang, Jing Ye, Binli Shang, Lei Dong, Hongfang Li, Jiabing Wu, Yuqi Cheng, Xiufeng Xu · 2023 · Journal of Molecular Neuroscience
  80. Inflammation Markers in Patients with Bipolar Disorder Who Have Committed Offenses and Their Relationship with Criminal Behavior
    Burcu Sırlıer Emir, Sevler Yıldız, Aslı Kazğan Kılıçaslan, Osman Kurt, Kerim Uğur, Muhammed Fatih Tabara, Süleyman Aydın · 2023 · Medicina
  81. Cognition in Bipolar Disorder: An Update for Clinicians
    Jennifer M. Nicoloro‐SantaBarbara, Marzieh Majd, Kamilla Woznica Miskowiak, Katharine Burns, Benjamin I. Goldstein, Katherine E. Burdick · 2023 · FOCUS The Journal of Lifelong Learning in Psychiatry
  82. Targeting BDNF with acupuncture: A novel integrated strategy for diabetes and depression comorbidity
    Kaiqi Zhang, Weihang Zhai, Xiaolei Ge, Xiaoqian Zhang, Wei Tian, Xu Zhai · 2023 · Heliyon
  83. Altered levels of cytokine, T- and B-lymphocytes, and PD-1 expression rates in drug-naïve schizophrenia patients with acute phase
    Yali Zheng, Qi Zhang, Xianqin Zhou, Linjuan Yao, Quanfeng Zhu, Zhengchuang Fu · 2023 · Scientific Reports
  84. Continuous theta burst stimulation for bipolar depression: A multicenter, double-blind randomized controlled study exploring treatment efficacy and predictive potential of kynurenine metabolites
    Annelies Dellink, Kaat Hebbrecht, Dieter Zeeuws, Chris Baeken, Gerard De Fré, Chris Bervoets, Sara De Witte, Bernard Sabbe, Manuel Morrens, Violette Coppens · 2024 · Journal of Affective Disorders
  85. Exploring the role of TNF-α, TGF-β, and IL-6 serum levels in categorical and noncategorical models of mood and psychosis
    Maja Pantović-Stefanović, Milica Velimirović, Vladimir Jurišić, Marija Puric, Marta Gostiljac, Sara Dodić, Ivana Minic, Milica J. Nesic, Tatjana Nikolić, Nataša Petronijević et al. · 2024 · Scientific Reports
  86. Investigation of choroid plexus variability in schizophrenia-spectrum disorders—insights from a multimodal study
    Vladislav Yakimov, Joanna Moussiopoulou, Lukas Roell, Marcel S. Kallweit, Emanuel Boudriot, Matin Mortazavi, Sergi Papiol, Lenka Krčmář, Mattia Campana, Eva Christina Schulte et al. · 2024 · Schizophrenia
  87. The Insulin-like Growth Factor Family as a Potential Peripheral Biomarker in Psychiatric Disorders: A Systematic Review
    Carlos Fernández-Pereira, Roberto Carlos Agís‐Balboa · 2025 · International Journal of Molecular Sciences
  88. rTMS ameliorates CUMS-induced anxiety-depression-like behaviour and cognitive dysfunction in rats by modulating the COX-2/PGE2 signalling pathway
    Yanjiao Pei, Huanhuan Liu, Jiqing Lang, Yuxin Chen, Fuping Zhang, Ran Hao, Jiao Li, Shina Gu, 彭琪, Jinggui Song et al. · 2025 · Journal of Psychiatric Research
  89. Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophrenia
    David R. Goldsmith, Courtney S. Ning, Gregory P. Strauss, Robin E. Gross, Jessica A. Cooper, Evanthia C. Wommack, Ebrahim Haroon, Jennifer C. Felger, Elaine F. Walker, Michael Tilghman Treadway et al. · 2025 · Neuropsychopharmacology
  90. Blood immuno-metabolic biomarker signatures of depression and affective symptoms in young adults
    Nicholas A Donnelly, Ruby S. M. Tsang, Éimear M. Foley, Holly Fraser, Aimee Hanson, Golam Mohammed Khandaker · 2025 · Brain Behavior and Immunity
  91. Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
    Diana O. Perkins, Clark D. Jeffries, Scott Richard Clark, Rachel Upthegrove, Cassandra Wannan, Naomi R. Wray, Qingqin S. Li, Kim Q., Elaine F. Walker, G. Paul Amminger et al. · 2025 · Schizophrenia
  92. Higher Serum C-Reactive Protein Levels in Catatonic Patients: A Comparison to Non-catatonic Patients and Healthy Controls
    Fuchun Zhou, Joseph W. Y. Lee, Qi-Hang Zhang, Zuo-Li Sun, Qijing Bo, Xiaoxiao He, Tian Han, Min Xiong, Chaohui Li, Chuanyue Wang · 2020 · Schizophrenia Bulletin
  93. Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double‐blind, placebo‐controlled, clinical multi‐centre trial
    Zhixing Li, Tianhong Zhang, Lihua Xu, YanYan Wei, Yingying Tang, Qiang Hu, Xiaohua Liu, Xiaolong Li, John M. Davis, Robert Smith et al. · 2020 · Early Intervention in Psychiatry
  94. Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study
    Therese Torgersen Bigseth, Mats Fredriksen, Jens Egeland, Eivind Andersen, Ole A. Andreassen, Gry Bang-Kittilsen, Ragnhild Sørum Falk, Tom Langerud Holmen, Egil Wilhelm Martinsen, Jon Mordal et al. · 2021 · Schizophrenia Research
  95. AUTOIMMUNE CONCEPT OF SCHIZOPHRENIA: HISTORICAL ROOTS AND CURRENT FACETS
    Margarita A. Mayorova, Бутома Борис Георгиевич, Leonid Pavlovich Churilov, Boris Gilburd, Nataliya N. Petrova, Yehuda Shoenfeld · 2021 · Psychiatria Danubina
  96. Implications of Gut-Brain axis in the pathogenesis of Psychiatric disorders
    Kurumi Taniguchi, Yuka Ikeda, Nozomi Nagase, Ai Tsuji, Yasuko Kitagishi, Satoru Matsuda · 2021 · AIMS bioengineering
  97. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
    Gerwyn Morris, Ken R. Walder, Michael Berk, Andre Ferrer Carvalho, Wolfgang Marx, Chiara C. Bortolasci, Alison Ruth Yung, Basant K. Puri, Michael H. J. Maes · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  98. Potential Transdiagnostic Lipid Mediators of Inflammatory Activity in Individuals With Serious Mental Illness
    Ulrika Hylén, Aidan J. McGlinchey, Matej Orešič, Susanne Bejerot, Mats B. Humble, Eva Särndahl, Tuulia Hyötyläinen, Daniel Eklund · 2021 · Frontiers in Psychiatry
  99. Peripheral inflammatory markers associated with brain volume reduction in patients with bipolar I disorder
    Shang‐Ying Tsai, Martha Sajatovic, Jung‐Lung Hsu, Kuo‐Hsuan Chung, Pao‐Huan Chen, Yu‐Jui Huang · 2021 · Acta Neuropsychiatrica
  100. Relationship Between Curative Effect and Serum Inflammatory Factors Level in Male Patients With First-Episode Schizophrenia Treated With Olanzapine
    Jun Ma, Yanting Zhang, Zhuowei Huang, Xuebing Liu, Luxian Lv, Yi Li · 2021 · Frontiers in Psychiatry